Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:EOLS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
06 Sep 24	SellUS$49,074	Sandra Beaver	Individual	3,276	US$14.98
30 Aug 24	SellUS$89,251	Tomoko Yamagishi-Dressler	Individual	5,631	US$15.85
04 Jun 24	SellUS$1,784,686	David Moatazedi	Individual	140,214	US$12.73
03 Jun 24	SellUS$97,203	Vikram Malik	Individual	7,500	US$12.96
14 May 24	SellUS$131,010	David Gill	Individual	10,361	US$12.72
13 May 24	SellUS$362,012	Vikram Malik	Individual	28,000	US$12.93
10 May 24	SellUS$30,814	Sandra Beaver	Individual	2,423	US$12.72
10 May 24	SellUS$43,761	Rui Avelar	Individual	3,441	US$12.72
10 May 24	SellUS$204,127	David Moatazedi	Individual	16,051	US$12.72
27 Mar 24	SellUS$86,431	David Moatazedi	Individual	6,236	US$13.86
19 Mar 24	SellUS$1,344,604	David Moatazedi	Individual	96,566	US$13.92
19 Mar 24	SellUS$78,978	Sandra Beaver	Individual	5,672	US$13.92
19 Mar 24	SellUS$384,350	Rui Avelar	Individual	27,603	US$13.92
22 Feb 24	SellUS$100,804	David Moatazedi	Individual	7,706	US$13.08
08 Dec 23	SellUS$822,396	David Moatazedi	Individual	82,648	US$10.09

Insider Trading Volume

Insider Buying: EOLS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of EOLS?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,248,032	1.97%
Public Companies	3,136,869	4.95%
Private Companies	3,381,326	5.34%
General Public	5,015,628	7.92%
VC/PE Firms	5,356,622	8.46%
Institutions	45,183,016	71.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.

Top Shareholders

Top 25 shareholders own 72.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.46%	Perceptive Advisors LLC	5,356,622	US$64.9m	-6.9%	1.42%
7.66%	Tang Capital Management, LLC	4,847,399	US$58.7m	0%	4.45%
6.33%	BlackRock, Inc.	4,008,182	US$48.5m	0%	no data
5.34%	Medytox Korea Co. Ltd	3,381,326	US$40.9m	0%	no data
5.05%	The Vanguard Group, Inc.	3,195,331	US$38.7m	7.04%	no data
4.95%	Daewoong Pharmaceutical Co., Ltd	3,136,869	US$38.0m	0%	no data
4.46%	Nantahala Capital Management, LLC	2,824,849	US$34.2m	-2.95%	2.72%
3.46%	Caligan Partners, LP	2,193,488	US$26.6m	1.19%	8.37%
2.16%	Stonepine Capital Management LLC	1,369,821	US$16.6m	-17.4%	5.85%
2.02%	State Street Global Advisors, Inc.	1,277,841	US$15.5m	-4.57%	no data
1.91%	Geode Capital Management, LLC	1,210,621	US$14.7m	0.92%	no data
1.85%	Great Point Partners, LLC	1,170,000	US$14.2m	-52.3%	4.74%
1.64%	Soleus Capital Management, L.P.	1,037,680	US$12.6m	-9.92%	1.07%
1.63%	Millennium Management LLC	1,029,670	US$12.5m	14.5%	0.01%
1.6%	Schroder Investment Management North America Inc.	1,014,960	US$12.3m	3.82%	0.04%
1.57%	Lord, Abbett & Co. LLC	995,449	US$12.1m	23.4%	0.04%
1.55%	Boothbay Fund Management, LLC	983,702	US$11.9m	-1.29%	0.39%
1.55%	Morgan Stanley, Investment Banking and Brokerage Investments	979,326	US$11.9m	-31.7%	no data
1.53%	D. E. Shaw & Co., L.P.	970,270	US$11.7m	11.4%	0.02%
1.51%	Assenagon Asset Management S.A.	955,555	US$11.6m	0.89%	0.02%
1.43%	Rice Hall James & Associates, LLC	904,900	US$11.0m	6.3%	0.59%
1.42%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	897,106	US$10.9m	51%	no data
1.34%	Soros Fund Management LLC	850,000	US$10.3m	0%	0.27%
1.19%	UBS Asset Management AG	753,532	US$9.1m	-2.06%	no data
1.04%	AWH Capital, L.P.	657,500	US$8.0m	-2.59%	7.09%